Shaka Brown was diagnosed with tuberculosis (TB) in November 2023. “I was dropped off at the emergency room in Miami, Florida,” he recalled. “In September, I thought I’d caught the flu, but after weeks of night sweats, fainting spells, and losing my hearing in my left ear—and over 50 pounds—I knew something was wrong.” Brown […] Continue reading ->
Better use of existing pneumonia and typhoid vaccines as well as new TB and pneumonia vaccines that are currently in clinical trials, could save over half a million deaths annually from drug resistant pathogens that don’t respond to antibiotics, according to a new WHO report on how vaccine strategies can reduce antimicrobial resistance (AMR). And […] Continue reading ->
The World Health Organization (WHO) this week recommended three new regimens for multidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB) tuberculosis (TB) that are far shorter than the current regimens and can be taken orally. The new regimens can cure patients in six to nine months rather than the usual 18 months and dispense with the painful injections […] Continue reading ->
Almost 15 years ago, when the University of Ghana established its Office of Research, Innovation, and Development, it did so with the goal of bolstering the West African nation’s research capacity. In the African region, where less than 0.5% of GDP is devoted to research, and a significant number of Africa’s educated is siphoned off […] Continue reading ->
One of the world’s largest global health initiatives (GHI), vaccine alliance Gavi, started in a UNICEF basement with a staff of five people. Nearly 25 years later, Gavi has grown into one of the most influential players on the global health stage, driving progress on key global health challenges. Yet several experts on global health […] Continue reading ->
A woman walks to an open tent and stands before a “camera” on a tripod, with a green curtain serving as her backdrop. “One, two, three…hold still…deep breath,” instructs the man in a black vest, speaking in Filipino, then presses the shutter. Within five minutes, the photo is ready. But this is no ordinary snapshot […] Continue reading ->
Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading ->
Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading ->
The elimination of tuberculosis cannot be achieved if medicines are locked in a “patent panoply,” according to Indian author and journalist Vidya Kishnan. Speaking to Garry Aslanyan on the most recent episode of Dialogues, a new series from the Global Health Matters podcast, the author of “Phantom Plague: How Tuberculosis Shaped History” said that “everything […] Continue reading ->
Clinical trial results presented at the Union World Conference on Lung Health in Paris on Wednesday provided evidence to support the use of four new, improved regimens to treat multi-drug resistant tuberculosis or rifampicin-resistant tuberculosis (MDR/RR-TB). The endTB clinical trial found three new drug regimens that can deliver similar efficacy and safety to conventional treatments […] Continue reading ->
You must be logged in to post a comment.